Cash and cash equivalents of $1.0 billion as of August 2, 2026
No outstanding borrowings under revolving line of credit
Operating cash flow of $695.9 million in first half of fiscal 2026
Returned $463.2 million through stock repurchases and dividends in first half of fiscal 2026
Board approved new $1.0 billion stock repurchase authorization in November 2025
two findings, in the order they were read
The disclosure now covers the twenty-six week period and continues to state no borrowings under the Credit Facility, consistent with the reason citing no outstanding borrowings.
The report says this changed. It does not say whether that is good or bad, so neither do we.
before · MD&A · 2026-05-03 → 2026-08-02
“During the thirteen weeks ended May 3, 2026 and May 4, 2025, we had no borrowings under our Credit Facility.”